Sex chromosomes direct disease risk and cellular aging independently of hormones
A synthesis of human and animal evidence reveals that genes on the X and Y chromosomes directly shape cancer defense, cardiac health, and brain aging throughout life.
Men and women experience many major medical conditions differently, from the incidence of cardiac trouble and leukemia to the progression of Alzheimer's disease. For decades, medical explanations for these disparities pointed almost entirely to circulating endocrine messengers such as estrogen and testosterone. While those biochemical signals exert profound physical effects, every nucleated cell in the human body also operates under genetic instructions delivered by its underlying pair of sex chromosomes.
A review published in the journal Science establishes that sex chromosomes exert a substantial influence on disease vulnerability, immune activity, and cellular aging on their own, operating alongside hormonal signals and independently of them. The synthesis was co-led by Dan Theodorescu, a physician-scientist who serves as chair and director of the University of Arizona Cancer Center and professor at the University of Arizona College of Medicine, alongside Dena B. Dubal of the University of California, San Francisco.
Evaluating evidence gathered across human population studies, laboratory mouse models, and genomic technologies, the authors demonstrated that genes on the X and Y chromosomes guide cellular function across the entire human lifespan. The analysis originated from discussions held at the 2025 National Institute on Aging Workshop on Sex Differences Impacting Human Health Across the Lifespan, including exchanges with Francesca Duncan of the Northwestern University Feinberg School of Medicine. Co-authors on the paper include Fabrisia Ambrosio of the Schoen Adams Research Institute of Harvard Medical School and Michael B. Stout of the Oklahoma Medical Research Foundation.
Why do men and women experience disease so differently?
Differences in disease susceptibility emerge from the distinct genetic dosages and structural behavior of the sex chromosomes inside individual cells. In standard human biology, females typically carry two X chromosomes while males carry one X chromosome and one Y chromosome. Because a double dose of every X-linked gene would create an imbalance in protein production, female mammalian embryos undergo a developmental process where one X chromosome in each cell is largely switched off early in development.
That shutdown is incomplete. The authors reported that several genes on the silenced X chromosome routinely escape inactivation and remain active, while other dormant genes can switch back on as tissues grow older. This escape pattern provides female cells with variable, supplemental doses of specific genetic instructions that male cells do not receive.
Parental inheritance creates an additional layer of variation in how cells function. Male cells invariably rely on an X chromosome inherited from the mother, paired with a father's Y chromosome. Female cells, by contrast, feature a mosaic mixture throughout tissue, where some cells activate the maternal X copy and neighbouring cells express the paternal X copy. In controlled experiments in mice, the physical origin of the active X chromosome mattered directly for cognitive health, as animals whose brain cells relied predominantly on the maternal X chromosome displayed accelerated brain aging and faster memory decline.
As Theodorescu explained, these foundational biological patterns operate continuously across human tissue. “X and Y chromosomes are often thought of as simple determinants for biological sex, but their role in human health is much larger,” Theodorescu said. “Our review shows that these chromosomes carry genetic instructions that shape how our cells age and how our bodies defend against major diseases throughout our lives.”12
What happens when cells alter or drop their sex chromosomes?
As the body ages, dividing cells can fail to replicate or segregate their genetic material accurately, causing some cells to lose a sex chromosome entirely. This phenomenon, which researchers track as mosaic chromosome loss, occurs at measurable rates across different tissue types and blood cell lineages. The physical disappearance of these chromosomes is being investigated both as a biological indicator of aging and as an active functional driver of severe age-related disorders.
In men, the loss of the Y chromosome, most frequently measured in circulating blood samples, correlates with elevated risks of cardiac disease, severe systemic infections, Alzheimer's disease, and various forms of cancer. Previous research led by Theodorescu demonstrated that the loss of the Y chromosome in male immune cells, known as T cells, as well as in carcinoma cells, enables tumors to evade immune detection, offering an explanation for why Y-chromosome loss correlates with higher mortality from carcinomas. Recent studies from Theodorescu's research group also revealed that the loss of the Y chromosome in normal-appearing tissues acts as an early warning sign and can mark a hidden zone of genetic vulnerability where cancer may subsequently emerge.
In women, the spontaneous loss of an X chromosome from circulating cells correlates with an increased likelihood of developing leukemia. The broader systemic consequences of X-chromosome loss remain largely unknown, representing an open scientific frontier.
“When we look inside human cells, we see that X and Y chromosomes are participants in health and disease throughout a person's life,” Theodorescu said. “In cancer, for example, our laboratory has found that tumors that lose the Y chromosome can evade the immune system, yet may respond better to immunotherapy. Understanding this biology could help us tailor treatment.”12
How could chromosomal differences change medical treatments?
Recognizing the distinct roles of the X and Y chromosomes could transform how doctors select medical interventions and how pharmaceutical sponsors structure clinical trials. When drug trials evaluate experimental therapies without accounting for sex chromosome dynamics, they risk obscuring why a therapeutic agent produces starkly different recovery rates or adverse reactions across different patient populations.
The review points toward targeted therapeutic opportunities that arise directly from chromosomal shifts. In oncology, tumors that drop the Y chromosome frequently escape baseline immune clearance, yet Theodorescu's laboratory found that these same Y-deficient malignant cells may show heightened sensitivity to immunotherapy drugs that restore immune surveillance. Identifying whether a patient's tumor has lost its Y chromosome could allow oncologists to identify candidates who will derive the greatest benefit from specific immune-checkpoint therapies.
The findings must be understood within the specific scope of the evidence assembled. The Science paper represents an interpretive review and synthesis of existing human epidemiological datasets, laboratory mouse experiments, and genomic studies, rather than a prospective clinical trial. Observed links between chromosome loss and conditions such as heart disease or dementia represent established correlations, but researchers are still untangling where chromosome loss acts as a direct molecular cause and where it serves as a cellular marker of cumulative physiological stress. Furthermore, specific inheritance mechanisms, such as maternal X chromosome reliance causing accelerated memory decline, have been demonstrated in mouse models and require further verification in human cohorts before informing diagnostic guidelines.
Research funding for the review was provided in part by the National Institutes of Health and the United States Department of Veterans Affairs. Looking ahead, the investigators argue that medical research must move beyond assuming biological sex is merely a hormonal variable. “Our hope is that this review will stimulate further investigation and bring greater awareness to the significant potential of studying the X and Y chromosomes in cancer and other diseases, with far-reaching diagnostic and therapeutic implications,” Theodorescu said. “This would help ensure that treatments and diagnostics are tailored to match every patient's unique profile. When clinical trials are designed to be sex-aware, researchers can turn these cellular differences into personalized medical care.”12
The record
5 sentences trace to 2 sources.
-
1
UA
U. Arizona Document · futurity.org · 16 Oct 2026 Sex chromosomes drive how bodies deal with cancer, heart health, and more See the source
-
2
N
news.arizona.edu Third-party reporting · news.arizona.edu Study: Sex chromosomes drive how bodies deal with cancer, heart health and longevity See the source